Sertraline drug class
Pro Research Analysisby 
Searched over 200M research papers
Sertraline Drug Class: An Overview
Introduction to Sertraline as an SSRI
Sertraline is a widely recognized antidepressant that belongs to the selective serotonin reuptake inhibitor (SSRI) class. This class of drugs functions by inhibiting the reuptake of serotonin (5-hydroxytryptamine; 5-HT) in the brain, thereby enhancing serotonergic transmission Comer2000Murdoch1992Heym1988. This mechanism is primarily responsible for its antidepressant effects.
Pharmacological Profile of Sertraline
Mechanism of Action
Sertraline selectively inhibits the serotonin transporter with minimal effects on noradrenaline (norepinephrine) and dopamine transporters Comer2000Doogan1988. This selective inhibition leads to increased serotonin levels in the synaptic cleft, which is believed to improve mood and alleviate symptoms of depression and anxiety Comer2000Murdoch1992Heym1988. Additionally, sertraline has shown no significant affinity for various other receptors, including histaminergic, dopaminergic, and muscarinic receptors, which contributes to its favorable side effect profile .
Pharmacokinetics
Sertraline is slowly absorbed after oral administration and undergoes extensive first-pass metabolism to form N-desmethyl-sertraline, a weakly active metabolite . The drug has an elimination half-life ranging from 22 to 36 hours, making it suitable for once-daily dosing Murdoch1992Devane2002. Steady-state plasma concentrations can vary significantly among individuals, but this variability does not typically necessitate therapeutic drug monitoring .
Clinical Efficacy and Applications
Treatment of Depression
Sertraline has demonstrated efficacy comparable to other antidepressants such as amitriptyline and dothiepin, and it is significantly more effective than placebo in treating major depressive disorder Murdoch1992Doogan1988. It is also the only antidepressant licensed in the UK for the prevention of recurrence of depression .
Other Indications
Beyond depression, sertraline is effective in treating a range of disorders, including obsessive-compulsive disorder (OCD), panic disorder, post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder Comer2000Bosch2008Jahr1994. Notably, it is the only SSRI approved for the treatment of PTSD, particularly effective in female patients and those with non-combat-induced PTSD .
Safety and Tolerability
Side Effects
Sertraline is generally well tolerated, with a side effect profile that includes gastrointestinal disturbances (nausea, diarrhea), insomnia, and sexual dysfunction Comer2000Murdoch1992Doogan1988. These side effects are usually mild and tend to decrease with continued treatment . Unlike tricyclic antidepressants, sertraline has minimal anticholinergic activity and is devoid of significant cardiovascular effects, making it a safer option for elderly patients and those with cardiovascular conditions Murdoch1992Muijsers2002.
Drug Interactions
Sertraline has a low potential for drug interactions, particularly at the level of the cytochrome P450 enzyme system, which is advantageous for patients on multiple medications Muijsers2002Devane2002. This characteristic makes it a preferable choice for elderly patients who are often on complex drug regimens .
Conclusion
Sertraline, as a selective serotonin reuptake inhibitor, offers a robust and well-tolerated option for treating various psychiatric disorders, including major depressive disorder, OCD, panic disorder, and PTSD. Its favorable pharmacokinetic profile, minimal side effects, and low potential for drug interactions make it a valuable medication in both general and specialized clinical settings.
Sources and full results
Most relevant research papers on this topic